Modulation of quinolinic and kynurenic acid content in the rat brain: effects of endotoxins and nicotinylalanine.

Modulation of quinolinic and kynurenic acid content in the rat brain: effects of endotoxins and nicotinylalanine.

Item
http://www.wikidata.org/entity/Q34760950
Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways.GPR35 activation reduces Ca2+ transients and contributes to the kynurenic acid-dependent reduction of synaptic activity at CA3-CA1 synapsesIsolation, characterization, and functional expression of kynurenine aminotransferase cDNA from the yellow fever mosquito, Aedes aegypti(1).Kynurenic acid antagonists and kynurenine pathway inhibitors.Kynurenine pathway inhibition as a therapeutic strategy for neuroprotection.The KMO allele encoding Arg452 is associated with psychotic features in bipolar disorder type 1, and with increased CSF KYNA level and reduced KMO expression.Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease.Kynurenines and Glutamate: Multiple Links and Therapeutic Implications.Kynurenic acid in human renal cell carcinoma: its antiproliferative and antimigrative action on Caki-2 cells.Role of kynurenines in the neurotoxic actions of kainic acid.Presynaptic kynurenate-sensitive receptors inhibit glutamate release.Kynurenine 3-mono-oxygenase inhibitors attenuate post-ischemic neuronal death in organotypic hippocampal slice cultures.Shifting the balance of brain tryptophan metabolism elicited by isolation housing and systemic administration of lipopolysaccharide in mice.Kynurenine hydroxylase inhibitors reduce ischemic brain damage: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(nitrophenyl)thiazol-2yl]-benzenesulfonamide (Ro 61-8048) in models of focal or global brain ischemia.Inhibition of stress-induced hepatic tryptophan 2,3-dioxygenase exhibits antidepressant activity in an animal model of depressive behaviour.Serotonin-immune interactions in elderly volunteers and in patients with Alzheimer’s disease (DAT): Lower plasma tryptophan availability to the brain in the elderly and increased serum interleukin-6 in DATOverview: Excitatory Amino Acids;Current Opinion in Therapeutic Patents June 1992
P2860

Modulation of quinolinic and kynurenic acid content in the rat brain: effects of endotoxins and nicotinylalanine.

Item
http://www.wikidata.org/entity/Q34760950
description
1991 nî lūn-bûn
@nan
1991 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Modulation of quinolinic and k ...... dotoxins and nicotinylalanine.
@ast
Modulation of quinolinic and k ...... dotoxins and nicotinylalanine.
@en
Modulation of quinolinic and k ...... dotoxins and nicotinylalanine.
@nl
type
label
Modulation of quinolinic and k ...... dotoxins and nicotinylalanine.
@ast
Modulation of quinolinic and k ...... dotoxins and nicotinylalanine.
@en
Modulation of quinolinic and k ...... dotoxins and nicotinylalanine.
@nl
prefLabel
Modulation of quinolinic and k ...... dotoxins and nicotinylalanine.
@ast
Modulation of quinolinic and k ...... dotoxins and nicotinylalanine.
@en
Modulation of quinolinic and k ...... dotoxins and nicotinylalanine.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Modulation of quinolinic and k ...... dotoxins and nicotinylalanine.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1471-4159.1991.TB06361.X
P407
P433
P478
P577
P698
P921